LUCD
Lucid Diagnostics IncNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$190.81M
P/E Ratio
—
EPS
$-0.69
Beta
1.25
52W High
$1.70
52W Low
$0.95
50-Day MA
$1.29
200-Day MA
$1.16
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Lucid Diagnostics Inc
Lucid Diagnostics Inc. is a commercial stage medical diagnostic technology company. The company is headquartered in New York, New York.
Fundamentals
| Revenue (TTM) | $4.71M |
| Gross Profit (TTM) | $-1.96M |
| EBITDA | $-48.77M |
| Operating Margin | -932.00% |
| Return on Equity | -711.00% |
| Return on Assets | -87.20% |
| Revenue/Share (TTM) | $0.05 |
| Book Value | $-0.33 |
| Price-to-Book | 2.16 |
| Price-to-Sales (TTM) | 40.55 |
| EV/Revenue | 50.91 |
| EV/EBITDA | -0.68 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 25.60% |
| Shares Outstanding | $170.36M |
| Float | $120.90M |
| % Insiders | 28.24% |
| % Institutions | 18.97% |
Data last updated: 4/8/2026